Quoin Pharmaceuticals, Ltd. American Depositary Shares QNRX
$7.26
-7.75%
at last close
Market Cap$15.81 million
P/E Ratio—
Div Yield—
Volume79.0K
52-Week Range
$3.25$41.80
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $30.00 (+313.2% upside)
Key Stats
- Today's Range
- $7.10 – $7.69
- 50-Day Range
- $3.99 – $8.25
- 52-Week Range
- $3.25 – $41.80
- Volume
- 79K shs
- Average Volume
- 1.11 million shs
- Market Cap
- $15.81 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 4.02
- Price / Sales
- —
Short Interest
- Short Interest
- 4.83%
- Days to Cover
- 1.78
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Related Stocks
Compare head-to-head: QNRX vs LLY·QNRX vs JNJ·QNRX vs ABBV·QNRX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.